Partyka Anna, Kłodzińska Aleksandra, Szewczyk Bernadeta, Wierońska Joanna M, Chojnacka-Wójcik Ewa, Librowski Tadeusz, Filipek Barbara, Nowak Gabriel, Pilc Andrzej
Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, PL 31-343 Kraków, Poland.
Pharmacol Rep. 2007 Nov-Dec;59(6):757-62.
GABAergic hypothesis of anxiety was introduced many years ago, however, a limited number of supporting data were accumulated so far and the role of GABA(B) receptors in behavioral processes related to the anxiety disorders has not been resolved. In the present study, we examined anxiolytic activity of CGP 36742, a potent and selective GABA(B) receptor antagonist, in rodent tests/models. We have demonstrated that CGP 36742 (30 mg/kg) is active in several animal tests detecting anxiolytic activity (the elevated plus-maze, conflict drinking test and four-plate test). Moreover, we examined the effects of another antagonist--CGP51176 and agonist--CGP 44532 of GABA(B) receptor in the four-plate test in mice. CGP 51176 (5 or 8 mg/kg) was inactive, while CGP 44532 (0.125 mg/kg) exhibited anxiogenic-like effect. These preclinical data further implicate GABA(B) receptor function in anxiety, and support the GABAergic hypothesis of this disorder.
焦虑的GABA能假说早在多年前就已提出,然而,迄今为止积累的支持数据有限,且GABA(B)受体在与焦虑症相关的行为过程中的作用尚未明确。在本研究中,我们在啮齿动物试验/模型中检测了强效选择性GABA(B)受体拮抗剂CGP 36742的抗焦虑活性。我们已证明,CGP 36742(30毫克/千克)在几种检测抗焦虑活性的动物试验(高架十字迷宫试验、冲突饮水试验和四板试验)中具有活性。此外,我们在小鼠四板试验中检测了另一种GABA(B)受体拮抗剂——CGP51176和激动剂——CGP 44532的作用。CGP 51176(5或8毫克/千克)无活性,而CGP 44532(0.125毫克/千克)表现出类似致焦虑的效应。这些临床前数据进一步表明GABA(B)受体功能与焦虑有关,并支持该疾病的GABA能假说。